Cat.#: ACPP-1224
| Despition | LAMP1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1177 | Recombinant Human Prostate Specific Antigen Protein (6×His Tag) (AC1177) | 50 µg | inquiry |
| ACPP-1821 | Human NT 4 Protein (AC1821) | 2 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1331 | GPR56 Blocking Peptide (AC1331) | 250 µg | inquiry |
| ACPP-1640 | Human Human GDF11 Protein (AC1640) | 100 µg | inquiry |
| ACPP-1448 | Human I TAC Protein, His (AC1448) | 5 µg | inquiry |
| ACPP-1466 | Human ATG10 Protein (AC1466) | 5 µg | inquiry |
| ACPP-1209 | CaMKII gamma Blocking Peptide (AC1209) | 250 µg | inquiry |
| ACPP-1459 | Human Midkine Protein, His (AC1459) | 5 µg | inquiry |
| ACPP-1836 | Human CHGA Protein (AC1836) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.